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Diagnostic value of end tidal capnography
in patients with hyperglycemia in the
emergency department
Ralphe Bou Chebl1,2*, Bryan Madden2, Justin Belsky3, Elie Harmouche2 and Lenar Yessayan4,5
Abstract
Background: Diabetic Ketoacidosis (DKA) is a potentially life-threatening emergency that requires prompt diagnosis
and treatment. In paediatric populations an end tidal capnography value greater than 36 mmHg was found to be
100 % sensitive in ruling out DKA.
Methods: A cross sectional observational study of adults ≥ 17 years of age presenting to the emergency
department between January 2014 and May 2014 with glucose > 550 mg/dL. In all patients, nasal capnography and
venous blood gas analysis were performed prior to any insulin or intravenous fluid administration. The diagnosis of
DKA was based on the presence of anion gap metabolic acidosis, hyperglycaemia and ketonemia. The overall
diagnostic performance (area under the curve [AUC]), sensitivity, specificity and likelihood ratios at different end
tidal CO2 (ETCO2) cut-offs were determined.
Results: 71 patients were enrolled in the study of which 21 (30 %) met the diagnosis of DKA. The area under the
curve for ETCO2 was 0.95 with a 95 % CI of 0.91 to 0.99. Test sensitivity for DKA at ETCO2 level ≥35 mmHg was
100 % (95 % CI, 83.9–100). An ETCO2 level ≤ 21 mmHg was 100 % specific (95 % CI, 92.9–100.0) for DKA.
Conclusion: Nasal capnography exhibits favourable diagnostic performance in detecting patients with or without
DKA among those who present to the emergency department with a glucometer reading > 550 mg/dL.
Keywords: Capnography, Diabetic ketoacidosis, Emergency department
Background
Diabetes mellitus is the most common endocrine disease
in the world. Acute complications of diabetes include se-
vere hyperglycaemia, diabetic ketoacidosis (DKA) and
hyperosmolar hyperglycaemic state (HHS). DKA is a po-
tentially life-threatening emergency characterized by
hyperglycaemia, metabolic acidosis and ketonemia along
with severe electrolyte abnormalities [1]. HHS is defined
as a state of severe hyperglycaemia without ketosis, with
a glucose >600 mg/dL but with levels frequently exceed-
ing 1000 mg/d. HHS is also characterized by neuro-
logical impairment, with the presentation ranging from
altered mental status to stupor. All hyperglycaemic
states require fluid resuscitation. The administration of
regular insulin to DKA patients via continuous intraven-
ous infusion or by frequent subcutaneous or intramus-
cular injections is the mainstay of treatment and is
needed to stop the breakdown of fatty acids into ketones
and to revert the acidotic state. While insulin is not
harmful in severe hyperglycemia, patients may achieve
euglycaemia with fluid resuscitation alone and an insulin
drip is not needed [2]. Capnography provides an indirect
means to detect metabolic acidosis. It monitors the par-
tial pressure of carbon dioxide (CO2) in respiratory
gases. The partial pressure of CO2 at end expiration is
termed end tidal CO2 (ETCO2) [3]. In response to the
decreased serum pH that is associated with a decrease in
serum bicarbonate, an increase would occur in alveolar
minute ventilation with a corresponding decrease in ar-
terial CO2 tension. Because ETCO2 closely approximates
arterial CO2 tension, it can potentially be used to predict
the presence or absence of DKA. Obtaining blood tests
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may be time-consuming. A rapid non-invasive sensitive
screening tool that rules out DKA in patients with se-
vere hyperglycaemia may avoid unnecessary administra-
tion of insulin infusion as part of initial therapy.
Similarly, a non-invasive test with high specificity in
identifying those with DKA; may expedite prompt diag-
nosis and treatment of DKA.
Goals of this investigation
In our emergency department, patients found to have
blood glucose >550 mg/dL, regardless of clinical status,
are taken to our high acuity area. This triage process
often leads to overcrowding the critical area and over-
whelming the medical team. For this subset of patients,
we wished to investigate the diagnostic characteristics of
ETCO2 to assess patients for DKA versus severe hyper-
glycaemia. We hypothesized that ETCO2 exhibited at
least a “fair discriminatory power” (i.e., 0.7 < AUC <0.8)
[4] for DKA in patients with blood glucose >550 mg/dL.
At 80 % power, alpha = 0.05, a ratio of sample sizes in
negative to positive groups with DKA of 4, and an area
under the receiver operating curve (ROC) of 0.75 (fair
discriminatory power) that is significant from the null
hypothesis value of 0.5 (no discriminatory power), a
minimum of 64 patients were required for the study. To
include at least this number of patients, a 6-month in-
clusion period was considered. The objectives of this
study were to characterize the overall diagnostic per-
formance (area under the curve [AUC]) of ETCO2 in pa-
tients with blood glucose > 550 mg/dL (30.6 mmol/L); to
determine the sensitivity, specificity, likelihood ratios at
different ETCO2 cut-offs; and to establish the degree of
correlation of both venous pH and serum bicarbonate
with ETCO2, and between venous pH and serum
bicarbonate.
Methods
Study design and setting
Cross sectional observational study was conducted at a
single emergency department in an urban tertiary care
centre in Detroit, Michigan, between January 2014 and
May 2014. Given that there was no harm or injury in
applying an end tidal monitor to patients’ nasal cannula,
a waiver of informed consent was granted. This study
was approved by our hospital’s institutional review board
(IRB #8560).
Selection of participants
As per our emergency department’s protocol, patients
with a known history of diabetes, or patients presenting
with specific complaints (generalized weakness, vomit-
ing, diaphoresis, altered mental status, polyuria) are
screened at triage with a point of care glucose measure-
ment. Inclusion criterion included a point of care
glucometer (Accu-Chek Inform II, Roche, Basel,
Switzerland) reading of “high” on presentation which
corresponds to a glucose level >550 mg/dL. Exclusion
criteria consisted of receipt of intravenous fluids or
insulin prior to the application of nasal capnography.
Methods and measurements
Patients were approached and identified by the nursing
staff in triage. Patient recruitment and enrolment oc-
curred at all times throughout the duration of the study.
All Eligible patients had nasal CO2 sampling cannula
placed by trained medical personnel while they were
being placed on the monitor and having their initial vital
signs taken. The cannula was attached to a capnograph/
capnometer (Microstream EtCO2 consumable, Smart
Capnoline, Philips Healthcare, Andover, MA). A single
ETCO2 value was documented when a stable waveform
was recorded on the monitor (Philips, intellivue MX700,
Philips healthcare, Andover, MA). Venous blood was
collected into collecting tubes for electrolytes, glucose,
beta hydroxybutyrate (ßHB), and complete blood count.
No time delays between the blood draws and the appli-
cation of the end tidal capnography. A venous blood gas
(VBG) sample was then collected in an arterial blood
collection syringe, sent to the laboratory over ice and
analysed by blood gas analyser (ABL800 Flex, Radiom-
eter America Inc., Westlake, OH). Measurements of
interest were pH and CO2 obtained from the VBG sam-
ple and measured serum bicarbonate (HCO3), ßHB, and
blood glucose from routine analysis of venous blood.
Capnography was compared to a reference standard for
diagnosing DKA defined as a triad of hyperglycaemia
>250 mg/dL, high anion gap metabolic acidosis and
ketonemia [5]. Ketonemia was defined as ßHB level
>3 mmol/l. The high anion gap acidosis was defined as
having an anion gap >12 with either one of the following
criteria; a serum bicarbonate ≤ 18 mmol/L or a blood
pH < 7.30. Given that the inclusion criteria was a glucose
>550 mg/dL, all patients met the hyperglycaemia
criterion.
Analysis
Statistical analysis was performed using SAS software
version 9.3 (SAS Institute, Inc., Cary, NC) and ROCs
were performed using MedCalc Statistical Software ver-
sion 13.2.2 (MedCalc Software bvba, Ostend, Belgium).
Categorical variables were presented as frequencies and
percentages. Continuous variables were intentionally
presented as median, interquartile range (IQR), mini-
mum and maximum to appreciate the spread of the
data. Mann Whitney rank sum test was used for group
comparisons for continuous data. Categorical data com-
parisons were performed using chi-square test. Pearson
coefficients were used to evaluate the correlation
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between ETCO2 and other arterial blood measurements
and between venous pH and serum bicarbonate. Sensi-
tivities and specificities were calculated at different levels
of ETCO2. For all analyses, P < .05 was considered
significant.
Results
Characteristics of study patients
Seventy-one consecutive patients were enrolled in the
study. The median age was 48.0 years (IQR 39–58) and
39 (55 %) were male. All patients had a known history of
diabetes. Twenty-one patients had DKA (prevalence
30 %). There was a significantly higher percentage of in-
sulin dependent diabetic patients in the DKA group
(57 % versus 24 %). Patient demographics, by presence
or absence of DKA are presented in Table 1. Laboratory
and diagnostic values are presented in Table 2. ETCO2
values ranged between 5 and 35 mmHg in patients with
DKA. Patients with DKA had higher median levels of
glucose and ßHB and lower partial pressure of CO2
(pCO2), ETCO2, serum bicarbonate, and pH.
Main results
The diagnostic performance of ETCO2 in diagnosing
DKA is represented in the ROC in Fig. 1. The area
under the curve [AUC] was 0.95 (95 % CI, 0.91 to 0.99).
Test sensitivity at ETCO2 level ≥35 mmHg was 100 %
(95 % CI, 83.9–100) and specificity was 68 (95 % CI, 53–
80). At an ETCO2 level less than or equal to 21 mmHg
specificity was 100 % (95 % CI, 92.9–100.0) and sensitiv-
ity was 57 % (95 % CI, 34–78). Table 3 provides the
sensitivities and specificities for DKA at different ETCO2
cut-offs.
Finally, there was a strong correlation between ETCO2
and serum bicarbonate levels (r = 0.88, P < .0001), coeffi-
cient of determination r2 = 0.76 (Fig. 2); and between
ETCO2 and VBG pH (r = 0.75, P < .0001), coefficient of
determination r2 = 0.56 (Fig. 3). There was also a strong
correlation between the VBG pH and measured serum
bicarbonate (r = 0.84, P < 0.0001), coefficient of deter-
mination r2 = 0.70.
Discussion
DKA is one of the few endocrine emergencies. It is char-
acterized by hyperglycaemia, ketonemia and metabolic
acidosis along with electrolyte abnormalities. It is a con-
dition that should be readily recognized and promptly
treated. The mainstay of medical treatment is intraven-
ous fluid rehydration, insulin replenishment through an
intravenous drip, electrolyte correction and identifica-
tion of the cause of the ketotic state [1].
DKA and severe hyperglycaemia are distinct clinical
entities with different treatments. Although the mainstay
treatment is fluid resuscitation, patients with DKA re-
quire insulin to reverse their ketotic state. Patients with
severe hyperglycaemia without ketosis require fluid re-
suscitation first and foremost; they may or may not need
insulin, and those who do infrequently require continu-
ous insulin infusion [6]. We sought to study the test
characteristics of ETCO2 in those presenting with blood
sugar greater than 550 mg/dL in an attempt to identify
thresholds which may help identify those with or with-
out concomitant DKA.
In this cohort of adult patients presenting with high
glucose, ETCO2 exhibited a good diagnostic perform-
ance (AUC 0.95), 95 % CI, 0.91 to 0.99. DKA was highly
prevalent in patients with glucose > 550 mg/dL (preva-
lence 30 %). At ETCO2 ≤ 21 mmHg, DKA was ruled in
(specificity 100 %) At ETCO2 ≥ 35 mmhg, DKA was
ruled out (sensitivity of 100 %). Furthermore, there was
a strong correlation between ETCO2 and PH as well as
bicarbonate, which would suggest that ETCO2 could be
useful in identifying DKA patients presenting with
Table 1 Patient characteristics
DKA (n = 21) Non-DKA (n = 50) P value
Age (years) median (IQR) 44 (29–48) 53 (41–62) 0.02
Males n (%) 12 (57) 27 (54) 0.03
IDDM n (%) 12 (57) 12 (24) 0.02
CKD n (%) 2 (9) 12 (24) 0.13
DKA diabetic ketoacidosis, CKD chronic kidney disease (baseline glomerular
filtration rate less than 60 ml/min), IQR interquartile range
Table 2 Outcome variables
DKA (n =21) Non-DKA (n = 50) P value
Glucose (mg/dL) 804 (650–897) 592 (564–675) 0.003
ETCO2 (mm Hg) 17 (9–27) 37 (34–41) <0.001
pH 7.16 (7.01–7.27) 7.38 (7.33–7.43) <0.001
pCO2 (mm Hg) 25 (15.0–29.7) 41.75 (37.0–47.0) <0.001
Bicarbonate (mmol/L) 9 (5–15) 24 (22–25) <0.001
Beta-Hydroxybutyrate (mmol/L) 11.35 (7.9–14.0) 0.37 (0.17–1.21) <0.001
Data presented as median (IQR). ETCO2 end tidal carbon dioxide, pCO2 partial pressure of carbon dioxide, CKD chronic kidney disease with baseline glomerular
filtration rate less than 60 ml/min, IDDM insulin dependent diabetes mellitus
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remarkably low PH levels and would allow faster and
more aggressive care.
Our study differs from other studies in several ways.
First, our cohort consisted of patients with blood glu-
cose > 550 mg/dl measured by glucometer. Second, we
used VBG pH to diagnose acidemia. Several studies have
shown that venous pH and pCO2 correlated highly with
arterial pH and pCO2 [7–9]. In patients with DKA, Ma
et al. demonstrated that venous and arterial pH have
also high agreement (mean bias −0.015 ± 0.006 pH units)
[10]. In this study, we also found a strong correlation be-
tween the VBG pH and measured serum bicarbonate (R
= 0.8395, P < 0.0001). Therefore, it is reasonable to re-
place the arterial blood gas with venous blood gas in the
evaluation of a patient with DKA. Third, we used ßHB
level >3 mmol/L to diagnose ketonemia. Although the
American Diabetes Association (ADA) [11] states that
urinary ketones are not reliable and that measurement
of ßHB is preferred, no specific diagnostic cut-offs are
mentioned. Studies that examined the correlation be-
tween serum bicarbonate and ßHB in DKA patients de-
termined that a serum ßHB level <3 mmol/L does not
correlate with an acidotic state [12, 13]. Fourth, our
study was conducted in adult patients. Most of the stud-
ies that have evaluated the relationship between ETCO2
and acidosis were in pediatric patients with type I dia-
betes [14–16]. These studies have shown a very high
diagnostic accuracy in pediatric patients. Both Fearon
et al. [14] and Gilhotra et al. [16] showed ETCO2 values
less than 29 mmHg could identify DKA with a specificity
of 100 and 91 %, respectively, whereas no patient with
ETCO2 values > 35 mmHg had DKA (sensitivity 100 %).
In contradistinction, in this study, the corresponding
specificity at ETCO2 values < 29 mmHg was only 88 %
(95 % CI, 75–95), however, the sensitivity at ETCO2
values > 35 mmHg was also 100 % (95 % CI, 84–100).
The different diagnostic accuracies at the same ETCO2
cut-offs between our study and the paediatric studies
may be secondary to different spectrum and distribution
of acute or chronic acid base disorders in adults com-
pared to the paediatric population or secondary to statis-
tical variation.
To our knowledge, only one study by Soleimanpour
et al. has evaluated the utility of ETCO2 in adults as a
screening tool for DKA with blood glucose > 250 mg/dL
and clinical symptoms of DKA [17]. The study was con-
ducted in an emergency department in Iran. The mean
glucose levels were 458 mg/dL in DKA patients and
362 mg/dL in non-DKA patients. The Soleimanpour
study showed that ETCO2 had a uniquely high diagnos-
tic accuracy (AUC 0.963) overall, and at ETCO2 cut-off
of 24.5 mmHg; it was highly sensitive (90 %) and specific
(90 %). The diagnostic performance of our test as mea-
sured by AUC was very high (AUC 0.95). Specificity at
Fig. 1 ROC curve showing overall diagnostic accuracy of ETCO2
Table 3 Sensitivities and specificities of end tidal capnography
Criterion Sensitivity 95 % CI Specificity 95 % CI +LR 95 % CI -LR 95 % CI
≤21 57.14 34–78.2 100.00 92.9–100.0 0.00 0.43 0.3–0.7
≤23 57.14 34–78.2 98.00 89.4–99.9 28.57 4.0–206.0 0.44 0.3–0.7
≤25 57.14 34–78.2 96.00 86.3–99.5 14.29 3.5–58.4 0.45 0.3–0.7
≤26 71.43 47.8–88.7 96.00 86.3–99.5 17.86 4.5–71.3 0.30 0.2–0.8
≤27 85.71 63.7–97.0 90.00 78.2–96.7 8.57 3.7–20.0 0.16 0.06–0.5
≤28 90.48 69.9–98.8 88.00 75.7–95.5 7.54 3.5–16.2 0.11 0.03–0.4
≤31 90.48 69.9–98.8 86.00 73.3–94.2 6.46 3.2–13.0 0.11 0.03–0.4
≤32 90.48 69.9–98.8 84.00 70.9–92.8 5.65 3.0–10.8 0.11 0.03–0.4
≤33 90.48 69.9–98.8 80.00 66.3–90.0 4.52 2.6–8.00 0.12 0.03–0.4
≤34 90.48 69.9–98.8 74.00 59.7–85.4 3.48 2.1–5.7 0.13 0.03–0.5
≤35 100.00 83.9–100 68.00 53.3–80.5 56.8 2.1–4.7 0.00
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Fig. 2 ETCO2 and bicarbonate correlation fit plot
Fig. 3 ETCO2 and venous blood gas PH correlation fit plot
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ETCO2 cut-off of 24.5 in our study was slightly higher
(96 % vs. 90 %); however our study did not demonstrate
a high sensitivity at this ETCO2 cut-off (sensitivity 57 %
vs. 90 %). Several patients in our cohort had DKA at
higher ETCO2 levels than 24.5 either because of chronic
respiratory acidosis disorders or because of coexisting
metabolic alkalosis.
Limitations
Our study has some limitations. First, the results can
only be applied to patients with blood glucose >550 mg/
dL (30.6 mmol/L). It is important to note that patients
with blood glucose level <550 mg/dL can be in DKA,
however we chose not to look at this subset of popula-
tion since it was studied earlier in the literature and be-
cause our main objective was to check the test
characteristics of the test among patients with severe
hyperglycemia [17]. A non-invasive test with a strong
positive predictive value for DKA would also be useful
to identify and urgently treat those with glucose levels
that might not otherwise be concerning. Second, al-
though the study was adequately powered to show that
the AUC was >0.50, it remains a relatively small study
with wide CIs around the sensitivity and specificity of
any of the cut-off points. A more precise estimate of
these cut-off points can be obtained by a larger sample
size. Third, it would have been helpful to see the AUC
for respiratory rate and compare it to the AUC for
ETCO2 and perform a cost analysis for the use of
ETCO2, however, this was not the aim of this study and
it is our hope that this study can stimulate future re-
search studies. Finally, It would also have been import-
ant to provide the data on other potential confounders
of ETCO2 within our patient population, however a sig-
nificant amount of our patients did not have any formal
diagnosis of Chronic Obstructive Pulmonary Disease
(COPD) or any Pulmonary Function Tests (PFTs) in our
records.
Conclusion
This single centre study suggests that end tidal capno-
graphy in adults presenting to the emergency depart-
ment with glucose levels > 550 mg/dL may useful in
identifying and ruling out DKA. The external validity of
the results should be confirmed by further prospective
studies.
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